More Deals Like Loxo On The Cards As Bayer Ups Ante In Oncology

 
• By Lucie Ellis-Taitt

Bayer's head of pharma Dieter Weinand chats to Scrip on the sidelines of the company's 2017 annual results conference in Leverkusen, Germany, about putting more skin in the game this time around as the second wave of immuno-oncology innovation spills into the market.  

Bayer 2017 FY Conference
L-R: Dieter Weinand, Kemal Malik and Werner Baumann at Bayer's annual results conference in Leverkusen • Source: Scrip/LEllis

More from Immuno-oncology

More from Anticancer